一个成功的多元组件计划扩大血管切除服务的MSI生殖选择玻利维亚玻利维亚.
Alison T Hoover1,2, Ana Cecilia Velasquez Rossi3, Silvia Velasco Parihuana3
1Emory University School of Medicine, Atlanta, Georgia, 30322, USA.
Gates open research
|October 13, 2025
概括
玻利维亚MSI成功地通过培训当地医生进行无头骨切除术 (NSV),降低成本,并利用社交媒体活动,提高了输精管切除的普及率. 这一举措大大提高了玻利维亚这种生殖健康选择的可用性和可接受性.
科学领域:
- 生殖健康 生殖健康
- 手术手术手术手术手术手术手术手术手术手术
- 公共卫生倡议 公共卫生倡议
背景情况:
- 玻利维亚的血管切除术利用率历史上较低,仅占2021年避孕方法的0.1%.
- 玻利维亚MSI生殖选择计划旨在提高全国范围内的输精管切除服务的可负担性,可访问性和质量.
- 该策略包括培训内部提供者进行输精管切除术,减少对昂贵的外部专家的依赖.
研究的目的:
- 描述MSI玻利维亚在2021年启动的输精管切除计划的实施和结果.
- 评估培训,降低成本和营销对输精管切除服务的影响.
- 评估在计划实施后的两年内,输精管切除手术的增加情况.
主要方法:
- 该计划结合了Engender健康供应-支持-环境-需求 (SEED) 模型的元素.
- 一个社交媒体运动在2021年11月提供了免费的输卵管切除术,以及由国际专家为四名医生提供为期一周的无头输卵管切除术 (NSV) 培训.
- 组织了合作伙伴关系和传播活动,随后的几年持续培训和营销.
主要成果:
- 在2021年的运动期间,有884名男性注册,有600多人被安排;在培训期间进行了127次监督的输卵管切除术,随后进行了300多次无监督的手术.
- vasectomy 的成本从 Bs. 降低了. 1500美元 (215美元) 转换为Bs. 850美元 (122美元).
- 玻利维亚MSI每年进行的输精管切除术数量从2019年的77例升至643例 (2021年),918例 (2022年) 和1135例 (2023年).
结论:
- 玻利维亚MSI通过NSV的内部医生培训,提高了输精管切除的可用性,质量和可接受性.
- 降低成本和有针对性的社交媒体广告是增加服务普及的关键因素.
- 该计划展示了一个成功的模型,用于扩大在低吸收环境中获得输精管切除服务的机会.
相关概念视频
Reproductive Cloning
Reproductive cloning is the process of producing a genetically identical copy—a clone—of an entire organism. While clones can be produced by splitting an early embryo—similar to what happens naturally with identical twins—cloning of adult animals is usually done by a process called somatic cell nuclear transfer (SCNT).
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
Somatic Cell Nuclear Transfer
In SCNT, an egg cell is taken from an animal and its nucleus is removed, creating an enucleated egg. Then a somatic cell—any cell that is not a sex...
In Vitro Fertilization
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...
Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...


